Health · Medical Research · 8 hrs ago
Hyaluronic acid injections may offer an alternative to surgery for Peyronie's disease
A Liverpool NHS trust is pioneering injections of hyaluronic acid as a possible treatment for Peyronie's disease, which causes scar tissue inside the penis.
The scarring can bend or shorten the penis and cause pain during erections, sometimes making sex impossible.
The condition affects an estimated one in ten men, with most cases occurring between ages 40 and 70.
Severe cases are currently treated with surgery, which can shorten the penis or worsen erectile dysfunction.
Early studies suggest the injections may reduce scarring and help straighten the penis while preserving sexual function.
Patients receive six to ten injections over about three months, depending on the severity of their condition.
Doctors hope the treatment can help some men avoid surgery, and say they want it to become available to more patients through the NHS.
Peyronie’s disease causes scar tissue in the penis, which can lead to curvature, shortening or pain during erections.
A course of hyaluronic acid injections is being developed at Liverpool University Hospitals NHS Foundation Trust as a possible alternative to surgery.
The injections are given directly into scar tissue over roughly three months, with patients receiving six to ten jabs depending on severity.
Early studies suggest the treatment may reduce inflammation and scarring and help straighten the penis.
Consultant urologist Marc Lucky says the approach could help preserve sexual function and avoid surgery for some men.
- Who
- Men with Peyronie’s disease may be candidates for the treatment.
- What
- A course of hyaluronic acid injections is being explored as a non-surgical treatment.
- When
- The treatment is given over roughly three months.
- Where
- Liverpool University Hospitals NHS Foundation Trust is pioneering the approach.
- Why
- Early studies suggest it may limit inflammation and scarring, straighten the penis and help preserve sexual function.
This story does not have two clearly opposing sides.
This story does not have a timeline yet.
- Estimated prevalence
- As many as one in ten men
- Typical age range
- Most cases strike between ages 40 and 70
- Injection course
- Six to ten jabs
- Cost per jab
- About £90
- Treatment site
- Liverpool University Hospitals NHS Foundation Trust
What people are saying
Men suffer in silence because they are embarrassed to seek help.
It's a low-risk and inexpensive intervention.
Having an effective non-surgical option available earlier is a very positive development for patients.